Contact
QR code for the current URL

Press release Box-ID: 532437

ARTES Biotechnology GmbH Elisabeth-Selbert-Str. 9 40764 Langenfeld, Germany http://www.artes-biotechnology.com
Contact Ms Dr. Melanie Piontek +49 2173 275870
Company logo of ARTES Biotechnology GmbH

Strategic cooperation between ARTES Biotechnology and PAC

ARTES and PAC join forces

(PresseBox) (Langenfeld, )
Artes and PAC join forces and combine their technologies and know-how.
ARTES Biotechnology specializes in recombinant protein production, process development in microbial expression systems and is a technology provider for pharmaceutical processes, while PAC (Peschek Analytic Consulting) is highly skilled in the field of protein analysis and quality control. Together with PAC, ARTES will now prospectively offer analysis of product quality control along side determination and quantification of by-products and/or process related residuals. The method analysis portfolio of PAC allows ARTES to offer method development and validation in accordance with GMP guidelines in the following analytical methods as HPLC-UV/DAD, Mass Spectrometry Ion Trap (LC-ESI/APCI MS/MS), Mass spectrometry Quadrupole (LC-ESI-MS), Gas Chromatography-Mass Spectrometry, Capillary Electrophoresis, Dynamic Light Scattering and Electron Microscopy.

Website Promotion

Website Promotion

ARTES Biotechnology GmbH

ARTES Biotechnology GmbH – www.artes-biotechnology.com
ARTES is a Germany-based biotechnology company, specializes in recombinant protein production, process development from microbial expression systems and technology transfer. ARTES offers generation of optimized production cell lines in proprietary yeast expression systems based on Hansenula polymorpha and vaccine development on virus like particle technology (VLP). In addition to genetic engineering, the company provides fermentation and downstream process development, analytical assay development and production cell line characterization. ARTES operates worldwide from its 850 sqm S1 facilities in Langenfeld. The company focuses on contract R&D for red and white biotechnology products.

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2022, All rights reserved

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.